Immatics (IMTX) Other Non-Current Liabilities (2019 - 2023)
Immatics' (IMTX) quarterly Other Non-Current Liabilities came in at $4303.8 in Q4 2023, down 89.96% year-on-year from $42850.4 in Q4 2022, and down 80.23% quarter-over-quarter from $21771.8 in Q3 2023.
Immatics (IMTX) Other Non-Current Liabilities (2019 - 2023) Analysis & Trends
Immatics has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $4303.8 for Q4 2023.
- Other Non-Current Liabilities for Q4 2023 came in at $4303.8, down 89.96% year-over-year; the trailing twelve-month figure through Dec 2023 was $4303.8 (down 89.96% YoY), and the FY2023 annual result was $4303.8, down 89.96% from the prior year.
- Other Non-Current Liabilities came in at $4303.8 for Q4 2023 at Immatics, down from $21771.8 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.3 million in Q4 2019 to a low of $4303.8 in Q4 2023.
- The 4-year median for Other Non-Current Liabilities is $49152.7 (2022), against an average of $270632.1.
- Across the five-year window, Other Non-Current Liabilities slumped 44.92% in 2022 and tumbled 89.96% in 2023, its largest moves.
- Immatics' Other Non-Current Liabilities stood at $2.3 million in 2019, then slumped by 96.63% to $77790.0 in 2021, then slumped by 44.92% to $42850.4 in 2022, then sank by 89.96% to $4303.8 in 2023.
- The last three Other Non-Current Liabilities figures came in at $4303.8 (Q4 2023), $21771.8 (Q3 2023), and $28312.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4,303.76 |
| Sep 30, 2023 | 21,771.81 |
| Jun 30, 2023 | 28,312.03 |
| Mar 31, 2023 | 35,420.28 |
| Dec 31, 2022 | 42,850.39 |
| Sep 30, 2022 | 55,455.09 |
| Jun 30, 2022 | 62,956.34 |
| Mar 31, 2022 | 70,707.28 |
| Dec 31, 2021 | 77,790.02 |
| Dec 31, 2019 | 2.31 Mn |